TaBriX, University and TB Alliance to develop drug-resistant tuberculosis treatments
TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight
Source: miragenews.com
Stay updated with breaking news from Tabrix Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight
Record results have been announced by The University of Manchester Innovation Factory, the organisation dedicated to driving commercialisation of